Maplight Therapeutics Inc.
- Address
- 800 Chesapeake Drive
Sponsor Overview
Specializations
Alzheimer’s disease psychosis
Maplight Therapeutics Inc. is focused on hallucinations and delusions associated with Alzheimer’s disease psychosis, with clinical research centered on symptoms that affect cognition, perception, and behavioral stability in this neuropsychiatric condition.
- Hallucinations
- Delusions
- Neuropsychiatric symptoms
The sponsor’s current research activity is directed toward treatment options for symptom relief in Alzheimer’s disease-related psychosis across multiple collaborating sites.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Efficacy and Safety Evaluation of ML-007C-MA in Treating Hallucinations and Delusions in Alzheimer's Disease Psychosis | Bulgaria Czechia France Hungary Italy Poland Portugal Romania Slovakia | Recruiting |
| Open-Label Long-Term Safety and Tolerability of ML-007C-MA (fesoterodine) in Adults with Hallucinations and Delusions of Alzheimer’s Disease Psychosis | Bulgaria Czechia France Hungary Italy Poland Portugal Romania Slovakia | Recruiting |
Data & Insights
This sponsor works with 1 molecule, of which 1 is not being studied by other sponsors.
This sponsor has worked with 27 sites across their trial portfolio.
Therapeutic Focus
- 1.Mental Disorders1 trial150 other sponsors
- 2.Nervous System Diseases1 trial449 other sponsors
Partnered Research Centres
27 centres- Address
- Bairro De Santo Antonio 47, 2560-280 Torres Vedras
- Address
- M R Stefanika 2427, 093 01 Vranov nad Topľou
- Address
- Ulitsa Dimitir Manov 17, 1408 Sofia
- Address
- Ulitsa Riga 3, 2304 Pernik
- Address
- Pekarska 53, Stare Brno, 602 00 Brno-střed
- Address
- Dozsa Gyorgy Utca 20-22, 3200 Gyongyos
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Maplight Therapeutics Inc..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.









